Skip to main content

Quark, Fujisawa Ink Drug-Discovery Deal for Stroke

NEW YORK, Aug. 6 - Quark Biotech and Japanese pharma firm Fujisawa today said they have penned a drug-discovery collaboration to treat stroke.

Terms of the deal call for Fujisawa to fund the research program, in which Quark will use its high-throughput technology.

Fujisawa will have worldwide exclusive rights on any resulting products, and Quark has an option to co-market certain products in the United States and the European Community.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.